263 related articles for article (PubMed ID: 20689132)
1. Proteomics and biomarkers for ovarian cancer diagnosis.
Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
[TBL] [Abstract][Full Text] [Related]
2. An overview of biomarkers for the ovarian cancer diagnosis.
Zhang B; Cai FF; Zhong XY
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):119-23. PubMed ID: 21632171
[TBL] [Abstract][Full Text] [Related]
3. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
4. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
Jurisicova A; Jurisica I; Kislinger T
Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
[TBL] [Abstract][Full Text] [Related]
5. Application of proteomics in ovarian cancer: which sample should be used?
Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer: biomarker proteomic diagnosis in progress.
Zhang Y; Guo B; Bi R
Appl Biochem Biotechnol; 2012 Oct; 168(4):910-6. PubMed ID: 22945560
[TBL] [Abstract][Full Text] [Related]
7. Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.
Williams TI; Toups KL; Saggese DA; Kalli KR; Cliby WA; Muddiman DC
J Proteome Res; 2007 Aug; 6(8):2936-62. PubMed ID: 17583933
[TBL] [Abstract][Full Text] [Related]
8. Searching for a system: the quest for ovarian cancer biomarkers.
Rodland KD; Maihle NJ
Cancer Biomark; 2010-2011; 8(4-5):223-30. PubMed ID: 22045355
[TBL] [Abstract][Full Text] [Related]
9. Proteins' promise--progress and challenges in ovarian cancer proteomics.
Koehn H; Oehler MK
Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
[TBL] [Abstract][Full Text] [Related]
10. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma.
Chung KH; Lee DH; Kim Y; Kim TH; Huh JH; Chung SG; Lee S; Lee C; Ko JJ; An HJ
J Proteome Res; 2010 Jan; 9(1):451-7. PubMed ID: 19902980
[TBL] [Abstract][Full Text] [Related]
12. Current clinical use of biomarkers for epithelial ovarian cancer.
Moore RG; Maclaughlan S
Curr Opin Oncol; 2010 Sep; 22(5):492-7. PubMed ID: 20613519
[TBL] [Abstract][Full Text] [Related]
13. Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer.
Gogoi R; Srinivasan S; Fishman DA
Expert Rev Mol Diagn; 2006 Jul; 6(4):627-37. PubMed ID: 16824035
[TBL] [Abstract][Full Text] [Related]
14. Status of tumor markers in epithelial ovarian cancer has there been any progress? A review.
Husseinzadeh N
Gynecol Oncol; 2011 Jan; 120(1):152-7. PubMed ID: 20934205
[TBL] [Abstract][Full Text] [Related]
15. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
Peng XQ; Wang F; Geng X; Zhang WM
Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
[TBL] [Abstract][Full Text] [Related]
16. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
18. From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.
Leung F; Diamandis EP; Kulasingam V
Biomark Med; 2012 Oct; 6(5):613-25. PubMed ID: 23075239
[TBL] [Abstract][Full Text] [Related]
19. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
